February 13, 2024- B. Braun Medical Inc. (B. Braun) announced the launch of its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL), the fifth product in its portfolio of Heparin premixed bags.
This new addition to the portfolio enhances the Company’s ability to serve the diverse needs of healthcare facilities and their patients for this high-alert medication. The B. Braun Heparin portfolio is manufactured using EXCEL® IV Containers which are not made with natural rubber latex, DEHP or PVC, placing a priority on patient and environmental safety. Additionally, the product is manufactured and distributed by B. Braun’s facility in Irvine, CA.
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.